Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

K-Dur Case: Reverse Payments Not “Established” Antitrust Violations – Judge

Executive Summary

Reverse payments from brand to generic companies in patent settlements are not "established" antitrust violations, an administrative law judge said in dismissing the Federal Trade Commission's antitrust case against Schering-Plough regarding K-Dur
Advertisement

Related Content

FTC Loses K-Dur Antitrust Case; Failure To Consider Schering Patent Cited
“Reverse” Payments Anti-Competitive In K-Dur Pact But Not All Cases – FTC
Cipro, Nolvadex Settlements No “Barr” To Generic Entrants, Courts Say
Bristol/FTC Settlement Brings PTO Standards Into Spotlight
FTC K-Dur case
FTC Backs Single 30-Month Stay On Generic Rx Approvals In Patent Litigation
FTC K-Dur Case Incorrectly Defines Market, Judge Says In Ruling For Schering
FTC K-Dur Case Incorrectly Defines Market, Judge Says In Ruling For Schering
FTC To Testify On Generic Reform; Agency Report May Be “Months” Away
Andrx/Aventis Settle With FTC: Agency Says Cardizem CD Generic Not Delayed
Advertisement
UsernamePublicRestriction

Register

PS040128

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel